Matches 201 - 250 out of 257 < 1 2 3 4 5 6 >
Match Document Document Title
5413572 Osmotic dosage system for liquid drug delivery  
An osmotic system is disclosed for delivering a beneficial agent formulation to an environment of use. The osmotic system comprises (a) an outside semipermeable wall, (b) a middle osmotically...
5401515 Coated active agent-containing article  
Aqueous coating compositions for forming elastomeric films around active cores (e.g., drugs) comprising a dispersion of pre-crosslinked polyorganosiloxane latex particles, colloidal silica...
5401512 Delayed release oral dosage forms for treatment of intestinal disorders  
An orally administrable pharmaceutical dosage form for selectively administering a drug to the intestine comprises a plurality of enteric coated granules of the drug contained in an enterically...
5397573 Laxative compositions  
Laxative compositions containing sennoside and menthol, pharmaceutically-acceptable esters of menthol, or mixtures thereof, preferably as peppermint oil; and methods for treating constipation by...
5397574 Controlled release potassium dosage form  
A pharmaceutical composition for oral administration of potassium salt in a form not irritating to the gastrointestinal mucosa comprises tablets or capsules of micropellets of a potassium salt,...
5391377 Biphasic release formations for lipophilic acids  
A pharmaceutical formulation comprises: (a) a C 12 -C 24 fatty acid, which may be saturated or mono- or poly-unsaturated, such as oleic or linoleic acid; and (b) a generally lipophilic...
5342624 Dispensing device  
Novel devices for the controlled release of active materials especially pharmaceutical are formed from at least two interpenetrating pieces. The male piece is water swellable and swells to...
5330759 Enteric coated soft capsules and method of preparation thereof  
Soft capsules coated with an enteric coating comprising a 1:1 copolymer of methacrylic acid and methyl or ethyl acrylate or methyl or ethyl methacrylate and a plasticizer without need for a...
5324280 Osmotic dosage system for delivering a formulation comprising liquid carrier and drug  
An osmotic system is disclosed for delivering a beneficial agent formulation to an environment of use. The osmotic system comprises (a) an outside semipermeable wall, (b) a middle osmotically...
5318779 Drug-impregnated ceramic  
A drug-impregnated ceramic to be embedded in a living body is disclosed, and includes a porous ceramic having pores with a pore size of 10 to 300 μm, a drug impregnating the porous ceramic via the...
5314696 Methods for making and administering a blinded oral dosage form and blinded oral dosage form therefor  
The invention relates to a method for making and administering a blinded oral dosage form and the blinded oral dosage form therefor, used for disguising the identity of tableted medications. The...
5314697 Stable extended release oral dosage composition comprising loratadine and pseudoephedrine  
A film-coated extended release oral dosage composition containing the nasal decongestant pseudoephedrine sulfate in a unique polymer matrix core and a film-coating on such core containing the...
5296233 Dual subcoated simulated capsule-like medicament  
A simulated capsule-like medicament comprising a dual subcoating comprising an initial subcoating of a water soluble film forming polymer, e.g. povidone and a secondary subcoating of a mixture of...
5296232 Pharmaceutical formulation which does not induce tolerance  
A controlled-release organic nitrate formulation for once-per-day oral administration is provided by spheres having a core which includes an organic nitrate, and a membrane surrounding the core...
5294439 Stabilized benzimidazole derivative and composition  
A stabilized physiologically active benzimidazole derivative having the formula (I): ##STR1## wherein R 1 is hydrogen atom, an alkyl group having 1 to 8 carbon atoms, a fluoroalkyl group having 1...
5283064 Large intestinal dissociative hard capsules  
A large intestinal dissociative hard capsule comprising a capsule mainly composed of chitosan, the viscosity at 20° C. of a solution obtained by dissolving the chitosan in an aqueous 1% by weight...
5281711 (S)-1-[10-chloro-6,7-dihydro-4-oxo-3-phenyl-4H-benzo[a]quino-lizin-1-yl) carbonyl]-3-ethoxypyrrolidine  
The compound (S)-1-[(10-chloro-6,7-dihydro-4-oxo-3-phenyl-4H-benzo[a]quin o-lizin-1-yl)c arbonyl]-3-ethoxypyrrolidine of the formula ##STR1## which has valuable pharmacological properties, is...
5252333 Lithium salt-containing pharmaceutical compositions  
The invention provides pharmaceutical and disinfectant compositions containing lithium salts of C 18 -22 polyunsaturated fatty acids. The compositions may be used in the treatment of conditions...
5238686 Sustained-release pharmaceutical preparation  
A sustained-release pharmaceutical preparation comprising an admixture of uncoated and/or single walled water soluble drug, such as aspirin, and dual walled coated drug. The dual wall structure has...
5206219 Oral compositions of proteinaceous medicaments  
Proteinaceous medicaments such as erythropoetin, insulin and calcitonin are formulated in a medium comprising a polyol pharmaceutical solvent combined as co-solvent with a lipid pharmaceutical...
5194464 Enteric film and preparatoin thereof  
An enteric film is produced by spraying on a material a mixed solution of (a) hydroxypropylmethylcellulose phthalate exhibiting a viscosity of about 136 to 204 centistokes as 10%...
5185157 Treatment of refractory Eosinophilia-Myalgia Syndrome with L-tryptophan composition  
A method of treating a human patient with refractory Eosinophilia Myalgia Syndrome via oral administration of an effective dosage range of from 1000 mg. to 3000 mg. of a pharmaceutical composition,...
5178873 Essential fatty acid treatment  
A method of inhibiting phospholipase A2 in the control of inflammation, wherein delta-6,9,12,15-octadecatetraenoic acid (stearidonic acid) and/or delta-8,11,14,17-eicosatetraenoic acid is...
5164195 Method of oral delivery with an adherent controlled-release salt sensitive capsule  
A salt sensitive capsule has been developed which dissolves in the mouth and releases the encapsulated internal ingredient(s). The outer salt sensitive shell maintains its integrity when kept at a...
5158776 Solid oral dosage forms of ifosfamide  
Solid oral ifosfamide formulations comprising a capsule containing a mass which consists essentially of the active substance ifosfamide and microcrystalline cellulose, or in the form of tablets...
5152994 Rapid method for interrupting or attenuating poly-drug dependency syndromes  
The administration to a poly-drug addict of ibogaine, ibogaine, tabernanthine, alkaloids in the family of apocynaceae, or their non-toxic salts have been discovered to interrupt the physiological...
5151273 Delayed-release pharmaceutical preparation  
Delayed-release tablets are formed by incorporating hemicellulose and a matrix-forming adjuvant which does not disintegrate in a pharmaceutical dosage form containing the active substance or...
5122384 Oral once-per-day organic nitrate formulation which does not induce tolerance  
A controlled-release organic nitrate formulation for once-per-day oral administration is provided by spheres having a core which includes an organic nitrate, and a membrane surrounding the core...
5110602 Pharmaceutical compositions comprising esters or amides as active ingredients  
The present invention relates to new pharmaceutical compositions characterizing that esters or amides are suspended or dissolved in a middle chain glyceride or a mixture thereof. These...
5108759 Endothelial envelopment drug carriers  
This application describes the preparation and in vivo testing of surface coatings and matrix materials, which when applied to or caused to comprise the carriers for drugs and diagnostic agents,...
5093130 Powder coated hydrogel capsules  
Methods and materials are provided for coating hydrogel capsules containing botanic tissue with an inert substance that decrease capsule surface adhesiveness and facilitates singulation and...
5077052 Chitosan derivatives useful in compositions for coating feedstuff additives intended for ruminants  
Novel organosoluble derivatives of chitosan, useful in coating biologically active feedstuff additives intended for ruminants, to provide coatings which are stable at a pH greater than 5 and which...
5064650 Controlled-release salt sensitive capsule for oral use and adhesive system  
A salt sensitive capsule has been developed which dissolves in the mouth and releases the encapsulated internal ingredient(s). The outer salt sensitive shell maintains its integrity when kept at a...
5064656 Uncoated pharmaceutical reaction tablet  
An uncoated compressed tablet which is used for the preparation of an orally applicable aqueous suspension or solution of a pharmaceutically active substance contains a mixture of the...
5057322 Method of treating mast cell disease  
A method of treating a patient suffering from mast cell disease comprising daily administration to such patient of from about 1 to about 150 mg of a pure narcotic antagonist, e.g., nalmefene or...
5032405 Oral pharmaceutical composition for acid sensitive proteinaceous agents  
An orally administrable formulation of a biologically active, acid sensitive, proteinaceous agent comprises a composition of a lyophilized mixture of the proteinaceous agent and maltose, optionally...
5023083 Azarbine composition  
A method for treating azaribine-responsive diseases in patient's who exhibit severe pyridoxal phosphate depletion following the oral administration of azaribine comprises first encapsulating...
5015479 Sustained release capsule or tablet formulation comprising a pharmaceutically acceptable dihydropyridine  
A sustained release capsule or tablet formulation suitable for once-daily administration comprises an adsorbate of a mixture of a pharmaceutically useful dihydropyridine and a polyvinylpyrrolidone...
4981695 Composition comprising L-dopa  
The present invention relates to a multiple-unit-dose comprising L-dopa as pharmaceutically active compound, whereby the composition provides a release of L-dopa in accordance with a test in...
4965089 Method and apparatus for the gelatin coating of caplets  
A caplet dipping machine includes a caplet holding plate including sets of caplet gripping collets on both sides thereof so that caplets can be dipped on one end, pushed through the plate and...
4910021 Targeted enternal delivery system  
A capsule for oral administration of a pharmaceutically active ingredient contains a pharmaceutical composition comprising the active ingredient, for example, a peptide, an absorption promoter and...
4849227 Pharmaceutical compositions  
A composition adapted to administer a pharmocologically effective amount of a pharmaceutical agent when ingested orally comprising (a) a pharmaceutical agent; (b) a lipid coating materials; and (c)...
4832686 Method for administering interleukin-2  
A biocompatible, biodegradable, bioerodible composite polymer matrix comprising interleukin-2 in an appropriate polymer. The polymer may be a polymer or copolymer of lactic acid, lactide,...
4816260 Personal protection device  
A personal protection device having a flexible support, and a breakable capsule at a front surface of the support, which capsule contains skunk essence. Upon attack, the user bends the support to...
4816259 Process for coating gelatin capsules  
This invention provides a new gelatin capsule formulation and subcoating for producing soft gelatine capsules having better mechanical strength and an improved capacity for adhering to known...
4800056 Process for making dispenser with cooperating elements  
A method of forming a dispenser for delivering a beneficial agent to a biological environment. A beneficial agent and an expandable composition are placed in a capsule made of fluid dissolvable...
4794000 Coacervate-based oral delivery system for medically useful compositions  
The present invention provides for an oral drug delivery system based on a two phase liquid coacervate system prepared from water and one or more surfactants selected from anionic, cationic,...
4670287 Method of film-coating hard capsules  
A method of film-coating hard capsules is provided which comprises subjecting, drug-filled hard capsules to a vacuum to remove air entrapped therein and then coating the evacuated capsules while...
4456628 Process for film-coating a particulate solid, and emulsions for conducting the process  
A process of coating a particulate medicinal agent; comprising the application to said medicinal agent of a liquid composition containing a water-insoluble film-forming agent, a lipophilic solvent,...
4452862 Pharmaceutical coating materials soluble or swellable in gastric juice and pharmaceutical dosage forms coated therewith  
Coating materials for pharmaceutical dosage forms contain, besides the conventional liquid or solid additives for pharmaceutical coatings, a binder comprising a synthetic polymer, prepared by...
Matches 201 - 250 out of 257 < 1 2 3 4 5 6 >